Survey about tolerance of the AS03-adjuvanted H1N1 influenza vaccine in children with rheumatic diseases

被引：6
|
作者：
Sengler, C. [1 ]
Niewerth, M. [1 ]
Kallinich, T. [2 ]
Nimtz-Talaska, A.
Haller, M.
Huppertz, H. -I. [3 ]
Minden, K. [1 ]
机构：
[1] German Rheumatism Res Ctr Berlin, Leibniz Inst, Epidemiol Unit, D-10117 Berlin, Germany
[2] Charite, Childrens Univ Hosp, Dept Pediat Pneumol & Immunol, D-13353 Berlin, Germany
[3] Klinikum Bremen Mitte, Bremen, Germany
来源：
CLINICAL RHEUMATOLOGY | 2014年 / 33卷 / 01期
关键词：
Children; Disease activity; Flare; H1N1 influenza vaccination; Rheumatic disease; JUVENILE IDIOPATHIC ARTHRITIS; SAFETY; IMMUNOGENICITY;
D O I：
10.1007/s10067-013-2435-8
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The objective of this study is to evaluate complications and changes in health status (disease activity and flare) in response to the AS03-adjuvanted H1N1 vaccine in children with rheumatic diseases. We conducted a nationwide survey addressing paediatric rheumatology sites who participated in the national paediatric rheumatology database. Ninety patients were documented-38 % under treatment with biologicals-of whom 18 % suffered from complications (10 % local and 8 % systemic) with no relevant changes in median disease activity or flare rate during 4 weeks following the vaccination. The adjuvanted H1N1 influenza vaccine seems to be adequately tolerated in children with rheumatic diseases.
引用
收藏
页码：137 / 139
页数：3
相关论文
共 50 条
  • [21] Enhanced Immune Response after a Second Dose of an AS03-Adjuvanted H1N1 Influenza A Vaccine in Patients after Hematopoietic Stem Cell Transplantation
    Gueller, Saskia
    Allwinn, Regina
    Mousset, Sabine
    Martin, Hans
    Wieters, Imke
    Herrmann, Eva
    Serve, Hubert
    Bickel, Markus
    Bug, Gesine
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (10) : 1546 - 1550
  • [22] Comparing the Immunogenicity of AS03-Adjuvanted 2009 Pandemic H1N1 Vaccine with Clinical Protection in Priority Risk Groups in England
    Yung, Chee-Fu
    Andrews, Nick
    Hoschler, Katja
    Miller, Elizabeth
    PLOS ONE, 2013, 8 (02):
  • [23] Clinical features of narcolepsy in children vaccinated with AS03 adjuvanted pandemic A/H1N1 2009 influenza vaccine in England
    Winstone, Anne Marie
    Stellitano, Lesley
    Verity, Christopher
    Andrews, Nick
    Miller, Elizabeth
    Stowe, Julia
    Shneerson, John
    DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY, 2014, 56 (11): : 1117 - 1123
  • [24] Immunogenicity and safety of the 2009 non-adjuvanted influenza A/H1N1 vaccine in a large cohort of autoimmune rheumatic diseases
    Saad, Carla G. S.
    Borba, Eduardo F.
    Aikawa, Nadia E.
    Silva, Clovis A.
    Pereira, Rosa M. R.
    Calich, Ana Luisa
    Moraes, Julio C. B.
    Ribeiro, Ana C. M.
    Viana, Vilma S. T.
    Pasoto, Sandra G.
    Carvalho, Jozelio F.
    Franca, Ivan L. A.
    Guedes, Lissiane K. N.
    Shinjo, Samuel K.
    Sampaio-Barros, Percival D.
    Caleiro, Maria T.
    Goncalves, Celio R.
    Fuller, Ricardo
    Levy-Neto, Mauricio
    Timenetsky, Maria do Carmo S.
    Precioso, Alexander R.
    Bonfa, Eloisa
    ANNALS OF THE RHEUMATIC DISEASES, 2011, 70 (06) : 1068 - 1073
  • [25] Randomized, Multicenter Trial of a Single Dose of AS03-adjuvanted or Unadjuvanted H1N1 2009 Pandemic Influenza Vaccine in Children 6 Months to <9 Years of Age
    Langley, Joanne M.
    Reich, Dennis
    Aggarwal, Naresh
    Connor, David
    Lebel, Marc H.
    Gupta, Anil
    Garfield, Hartley
    Li, Ping
    Madan, Anu
    Vaughn, David W.
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2012, 31 (08) : 848 - 858
  • [26] Increased risk of anaphylaxis following administration of 2009 AS03-adjuvanted monovalent pandemic A/H1N1 (H1N1pdm09) vaccine
    Rouleau, Isabelle
    De Serres, Gaston
    Drolet, Jean Philippe
    Skowronski, Danuta M.
    Ouakki, Manale
    Toth, Eveline
    Landry, Monique
    Menard, Suzanne
    Gagnon, Remi
    VACCINE, 2013, 31 (50) : 5989 - 5996
  • [27] Enhanced immune response after a second dose of an AS03-adjuvanted H1N1 influenza. A vaccine in patients after haematopoietic stem cell transplantation
    Gueller, S.
    Mousset, S.
    Martin, H.
    Serve, H.
    Bug, G.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S218 - S218
  • [28] AS03A-Adjuvanted Influenza A (H1N1) 2009 Vaccine for Adults up to 85 Years of Age
    Roman, Francois
    Vaman, Tejaswini
    Kafeja, Froukje
    Hanon, Emmanuel
    Van Damme, Pierre
    CLINICAL INFECTIOUS DISEASES, 2010, 51 (06) : 668 - 677
  • [29] Pregnancy and safety outcomes in women vaccinated with an AS03-adjuvanted split virion H1N1 (2009) pandemic influenza vaccine during pregnancy: A prospective cohort study
    Tavares, Fernanda
    Nazareth, Irwin
    Monegal, Javier Sawchik
    Kolte, Ida
    Verstraeten, Thomas
    Bauchau, Vincent
    VACCINE, 2011, 29 (37) : 6358 - 6365
  • [30] Reassessment of the risk of narcolepsy in children in England 8 years after receipt of the AS03-adjuvanted H1N1 pandemic vaccine: A case-coverage study
    Stowe, Julia
    Andrews, Nick
    Gringras, Paul
    Quinnell, Timothy
    Zaiwalla, Zenobia
    Shneerson, John
    Miller, Elizabeth
    PLOS MEDICINE, 2020, 17 (09)
12345